Catalog  |  Cart  |  Log In

 

Implementation of Laboratory Automation for the Analysis of STR Loci

 

Robert Bever, Dawn Jarvis, Debbie DiPierro, and Kevin McElfresh.
The Bode Technology Group, Inc., 21515 Ridgetop Circle, Suite 140, Sterling Va. 20166.

× Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø × Ø

STR loci are polymorphic genetic markers routinely used in forensic casework, parentage analysis and the construction of felon databases. The PowerPlexÔ system amplifies eight different loci simultaneously that can be detected by using two different fluorescent labels (Fluorescein tagged Gamma STRÔ loci D16S539, D7S820, D13S317, and D5S818 and the carboxy-tetramethylrhodamine tagged STR loci CSF1PO, TPOX, TH01, and vWA). Analysis of the eight loci contained in the Promega PowerPlexÔ system results in an average match probability exceeding one in one hundred million and an average power of exclusion greater than 99.7% (1). Even though STR methods are less labor intensive than RFLP methods, further operational efficiencies for STRs can be achieved through automation (2). In order to improve operational efficiencies while maintaining quality, we have automated the STR procedure and implemented the following systems:

The purpose of this study was to validate and implement the use of the PowerPlexÔ, Fitzco FTAÔ Paper, and Rosys workstation in our laboratory. The robotic system was chosen based on its specimen throughput, precision, and ability to accommodate a plate washer, incubator and a microplate-hole punch device. The isolation of DNA from the Fitzco FTAÔ paper was validated based on the consistent quality and quantity of amplified product resulting from the purification of DNA. The ability to accurately amplify all of the observable alleles for a specific locus was part of the criterion for validating the PowerPlexÔ and the use of the FTAÔ protocol in our laboratory. Contamination studies were done to evaluate isolation and amplification of DNA. The final analysis of the STR products after electrophoresis was performed on the Hitachi FMBIO II®. Validation of the Hitachi FMBIO II® was previously presented (3,4).

I. METHODS

Isolation of DNA

Unless specifically stated DNA was isolated using the Promega Wizard® Kit (5) or by using the following modification of the Fitzco FTAÔ protocol.

Manual Purification of DNA From Blood Using the Fitzco FTAÔ Paper

Five microliters of blood were spotted onto the FTAÔ paper and allowed to dry for one hour at room temperature. A one millimeter punch from the paper was placed into the well of a 96 well microtiter plate and 200 microliters of the Fitzco Purification reagent was added. The plate was incubated at room temperature for 5 minutes after which the buffer was removed. This procedure was repeated two times. After removing the third addition of Purification reagent, 200 microliters of 10 mM Tris, pH 8.0 was added. The plate was allowed to sit at room temperature for five minutes and then the reagent was removed. This procedure was repeated once. The final 10 mM Tris buffer was removed and the plate was dried at room temperature for at least an hour or for thirty minutes at 56oC. The 1 mm punch containing the purified DNA was placed into a PCR reaction tube and amplified in a final reaction volume of 25 microliters. The purified DNA punch represented 2.5 microliters of the solution. The protocol for the amplification of the PowerPlexÔ system, CTTv and FFFL quadriplex system is described in the "Amplification Protocols".

Automated Processing of FTAÔ Paper Using the Rosys Plato Gene Machine

Five microliters of blood were transferred to each well of the Fitzco FTAÔ Plate which is a 96 well microtiter plate containing the FTAÔ paper. The blood on the FTAÔ plate was dried in the Rosys incubator for forty-five minutes at 56oC. Following drying, the plate was transferred to the vacuum assisted wash station for purification of the DNA. Utilizing the appropriate Rosys procedural script, the following purification steps were performed for each blood spot sample:

· 200 microliters wash with Fitzco Purification reagent with a one minute incubation (Repeat five times)

· 200 microliters wash with 10 mM Tris (pH 8.0) with one minute incubation (repeat three times)

· 200 microliters wash with absolute ethanol (repeat three times)

Following the purification steps and the ethanol wash, the plate was transferred to the incubator and dried for 45 minutes at 56o C. After drying, a 1mm punch from the FTAÔ paper was delivered into a Robbins Scientific 96 well amplification plate using the Rosys gene machine integrated punching station. The 1mm punch containing the purified blood spot was amplified in a final reaction volume of 25 microliters (The 1mm blood punch replaces 2.5 micro liters of solution.) The Robbins 96 well amplification plate was sealed with plate caps and manually placed in the Perkin-Elmer 9600 thermal cycler. The protocol for the amplification of the PowerPlexÔ systems, FFFL, and CTTv quadriplex system is described in the "amplification protocol" section.

Amplification Protocol

For DNA isolated from liquid blood, an average of twenty nanograms of genomic DNA was amplified using the Perkin-Elmer 9600 following the protocol described in the Promega Technical Manuals for the PowerPlexÔ System or the GenePrintÔ Fluorescent quadriplex systems (6,7). For DNA isolated from dried blood stains on Fitzco FTAÔ paper, a 1 millimeter punch from a five microliter spot of blood was amplified. DNA was not quantified from dried blood stains on FTAÔ paper. Amplified Multiplex product was electrophoretically separated in a 32 cm denatured 6% polyacrylamide gel on a Life Technologies SA32 gel box. The gel was pre-run (using 1X TBE) for 15 minutes at 30 watts constant power. The samples were mixed with tracking dye, heat denatured for 2 minutes at 95oC, loaded onto the gel, and electrophoresed at 30 watts for approximately 210 minutes at constant power. Appropriate negative and positive controls were included for every amplification reaction and loaded onto the gels along with the appropriate allelic ladders from the Promega STR kits.

Following electrophoresis of the samples, the gels were analyzed on the Hitachi FMBIO II®. For the PowerPlexÔ systems the Gamma STRÔ loci (D16S539, D7S820, D13S317, and D5S818) were scanned at 505 nm and the carboxy-tetramethylrhodamine (TMR) labeled primers CSF1PO, TPOX, TH01, and vWA (CTTv) were analyzed at the 585 scan. The GenePrintÔ quadriplex fluorescein labeled primers CTTv and F13A01, FESFPS, F13B, and LPL (FFFL) were scanned at 505 as described in the manual (6). Specimen genotypes were determined using the Hitachi FMBIO® software which converts the molecular base-pair sizes to alleles descriptions based on the tandem repeat number.

II. RESULTS

A. PowerPlexÔ Validation and Implementation

The Promega PowerPlexÔ system was evaluated with regards to its accuracy, consistency, sensitivity and ability to amplify DNA from different extraction methods as well as from different biological substrates.

1. Accuracy: 394 samples were amplified and analyzed in duplicate with the PowerPlexÔ kit and compared with each other. 184 of these 394 samples were previously amplified and analyzed with the fluorescein CTTv quadriplex primers. No discrepancies were observed between the 184 samples amplified with the fluorescein tagged CTTv primer and the TMR tagged CTTv primers of the PowerPlexÔ system. Furthermore no discrepancies were observed with the Gamma-STRÔ (D16, D7, D13, D5) systems of the PowerPlexÔ which had been run in duplicate.

Three specimens out of the 394 contained the TH01 genotype 9.3, 10. These specimens were further analyzed using the monoplex TH01 system and the results were consistent with that observed with the PowerPlexÔ. The ability to detect the 9.3, 10 genotype demonstrated the resolution capabilities of the electrophoretic gel system.

2. Sensitivity: K562 DNA was serially diluted from 50 ng to 0.1 ng and amplified with the PowerPlexÔ system. 50 ng to 0.25 ng of DNA could reliably be analyzed for all of the loci. 0.1ng of DNA was detectable for some of the loci; however, the CSF1PO, D7S820, and D5S818 were too faint to reliably determine their genotype. This sensitivity assay was repeated with DNA isolated from whole blood and similar results were observed.

3. Extraction Method: DNA isolated from the same individuals was isolated by the following methods: Phenol-Chloroform extraction, Promega Wizard® Kit, Chelex extraction, and FTAÔ paper extraction. The DNA was amplified and analyzed using the Promega PowerPlexÔ system and protocol. No discrepancies were detected based on the different methods of DNA extraction.

4. Biological Substrates: DNA isolated from blood, buccal cells, skin cells, and hair roots were reproducibly amplified using the Promega PowerPlexÔ system.

B. FTAÔ Validation

Storage, purification and amplification of DNA purified from blood spotted onto FTAÔ paper was validated with regards to the accuracy and consistency of results, ability of the DNA to be amplified from a variety of primers, sensitivity of the reaction, and potential contamination of the DNA.

The procedure for storing blood and purifying DNA using the FTAÔ paper was validated for the following parameters.

1. Accuracy: Thirty samples were processed in duplicate onto FTAÔ paper, and the 1mm punch containing purified DNA was amplified with the Promega PowerPlexÔ, fluorescent CTTV quadriplex, and fluorescent FFFL quadriplex. Additionally, the DNA from these samples was isolated previously with the Promega Wizard® Kit. The genotype results from the duplicate FTAÔ isolations and the results from the DNA extracted with the Wizard® Kit were compared to each other. A total of 271 allele designations were made for the thirty samples that were processed in triplicate. No discrepancies were detected for any of the samples. However, the amplification product of the FFFL STR quadriplex, resulting from the DNA purified from the 1mm FTAÔ punch, was less intense than the PowerPlexÔ or the fluorescent CTTV quadriplex amplification products resulting from DNA purified from the FTAÔ paper. Two additional amplification cycles should increase the intensity of the amplification product.

2. Reaction Sensitivity: One microliter to one thousand microliter blood spots were processed with a 1 mm punch, and the purified DNA was amplified using the Promega PowerPlexÔ. Equal amounts of amplified product were visually detected from the differing spots of blood. The one microliter spot of blood amplified as well as the 5, 10, 100 and 1000 microliter spots of blood. No discrepancies were detected with regards to the allele designations.

3. Contamination studies:

a. 20 blood specimens were spotted onto one FTAÔ card and allowed to dry. After the spots were dried, the 1mm punch was placed into separate amplification tubes and processed as normal except that the pipetting and aspiration of purification reagents and 10mM Tris were all performed with the same pipette tip to investigate potential contamination and mimic a robotic procedure. Appropriate positive and negative controls were included in the study. The DNA was amplified using the PowerPlexÔ system. No evidence of contamination was detected between the samples and the negative controls revealed no amplification product.

b. Five microliter samples from eight individuals were spotted 5 mm apart on one FTAÔ card and purified in one container prior to punching out the 1mm spot. The purified DNA was amplified using the Promega PowerPlexÔ and FFFL STR systems. No sign of contamination was seen between the eight individuals or the substrate control.

C. Incorporation of the PowerPlexÔ, FTAÔ Paper and the Rosys Robotic System

The Rosys Plato Gene Machine was utilized to integrate the use of the FTAÔ paper in the amplification of the DNA. The Rosys instrument was used to semi-automate the dispensing of blood onto FTAÔ paper, purify the DNA from the blood, punch the FTAÔ paper into the 96 well amplification plate, and distribute the amplification reaction mixture.

1. Accuracy and Consistency: 96 blood samples were distributed onto FTAÔ paper (1mm punch from a 5 microliter blood spot) in the FTAÔ 96 well plate, purified to DNA, punched out using the Rosys semi-automated well punch into the Robbins Scientific 96 well amplification plate and amplified on the Perkin-Elmer 9600. The samples were analyzed using Promega PowerPlexÔ and the FFFL quadriplex system. These samples had been previously isolated manually. No discrepancies were seen in the genotype designations for the 96 samples.

2. Reliability: 96 samples were processed on the Rosys robot on a daily basis for five days in duplicate and analyzed with the PowerPlexÔ system. Currently, a 98% reliability rate can be attributed to the instrument. On occasion, a "blood punch" is not delivered to the well of the Robbins scientific plate. This phenomenon is currently being investigated by the Rosys corporation.

 

III. DISCUSSION AND SUMMARY

The processing of samples for analysis by STR technology can become more efficient by the purification of DNA from Fitzco FTAÔ paper and amplification of the DNA using the Promega PowerPlexÔ system. The Fitzco FTAÔ paper permits one to store blood at room temperature at length and allows one a convenient and efficient method to purify DNA. The purified DNA is bound to the FTAÔ paper and presents itself as a template for amplification. Storage and processing of the blood to purified DNA using the FTAÔ purification process has been shown to be an accurate, reliable process which is free of potential contamination. In our laboratory, the manual processing of DNA for amplification using FTAÔ paper has reduced the amount of labor time by 40% as compared to extraction by phenol chloroform or salt precipitation.

The PowerPlexÔ system amplifies eight different loci simultaneously and can be detected by two different fluorescent dyes (Fluorescein tagged Gamma STRÔ loci D16S539, D7S820, D13S317, and D5S818 and the carboxy-tetramethylrhodamine STR loci CSF1PO, TPOX, TH01, and vWA). These validation studies have shown that the PowerPlexÔ is accurate, consistent, sensitive below 1 nanogram of DNA and versatile with regards to the method of isolation and original biological substrate. Amplification of 8 loci and analysis of the products in one gel lane with the use of the Hitachi FMBIO II® decreases labor time considerably by minimizing the number of gels that a technician must prepare. Also, fewer pipetting steps are required during amplification and gel loading.

Incorporation of these procedures with a semi-automated processing of the samples with the Rosys Gene Machine has been shown to produce accurate and reliable results with improved operational efficiencies. At this time the only technical setback is the punching of the FTAÔ paper into the wells. Once this problem is solved it is anticipated that the dispensing of blood, storage of blood, purification of DNA, and addition of amplification reagents will become an automated process which will allow the lab to handle at least 200 samples per day. Automation will assist in the processing of large number of samples on a daily basis for the building of DNA databases or for the processing of paternity casework. This validation study has demonstrated that automation will greatly enhance the laboratory efficiency and still maintain the quality of results as accurate and reliable.

 

REFERENCES

 

1. Schumm, James W., et al. Automated Fluorescent Detection of STR Multiplexes- Development of the GenePrintÔ PowerPlexÔ and FFFL Multiplexes for Forensic and Paternity Applications. In: Proceedings from the Seventh International Symposium on Human Identification. 1996; Promega Corporation pp. 70- 88.

2. Belgrader, Phillip et al. 1995. Automated DNA Purification and Amplification from Blood-stained cards using a Robotic Work-station. Biotechniques 19; 426-432.

3. McElfresh, Kevin et al. A Comprehensive Analysis of Short Tandem Repeat Polymorphisms: Detection Methods, Population Genetics, NRCII, and Proficiency Tests. In: Proceedings from the Seventh International Symposium on Human Identification. 1996; Promega Corporation, pp. 89 - 95.

4. Yuen, Warner. Using the FMBIO® for New Three Color Enhancement fluorescence STR Analysis and CODIS Data Bank Compatibility. In: Proceedings from the Seventh International Symposium on Human Identification. 1996; Promega Corporation p. 124.

5. Promega Corporation, Wizard® Kit Technical Manual.

6. Promega Corporation, GenePrintÔ STR Systems Technical Manual, #TMD004.

7. Promega Corporation, GenePrintÔ STR Systems Technical Manual, #TMD008.


Go to proceedings home page